Fig. 2.
Fig. 2. FACS analysis of PSGL-1 on neutrophils. / Control mice were treated with increasing doses of PSGL-1–blocking mAb 4RA10 (1 μg, 3 μg, 10 μg, and 100 μg) for more than 20 minutes. Peripheral blood was collected and processed for FACS analysis of GR-1+ cells.

FACS analysis of PSGL-1 on neutrophils.

Control mice were treated with increasing doses of PSGL-1–blocking mAb 4RA10 (1 μg, 3 μg, 10 μg, and 100 μg) for more than 20 minutes. Peripheral blood was collected and processed for FACS analysis of GR-1+ cells.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal